[go: up one dir, main page]

WO2003069309A3 - Dosage immunocapteur et fonctionnel pour complexe i mitochondrial - Google Patents

Dosage immunocapteur et fonctionnel pour complexe i mitochondrial Download PDF

Info

Publication number
WO2003069309A3
WO2003069309A3 PCT/US2003/004567 US0304567W WO03069309A3 WO 2003069309 A3 WO2003069309 A3 WO 2003069309A3 US 0304567 W US0304567 W US 0304567W WO 03069309 A3 WO03069309 A3 WO 03069309A3
Authority
WO
WIPO (PCT)
Prior art keywords
complex
diseases
screening
activity
immunocapture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/004567
Other languages
English (en)
Other versions
WO2003069309A2 (fr
Inventor
Michael F Marusich
Roderick A Capaldi
Devin Oglesbee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Oregon
Oregon State
Original Assignee
University of Oregon
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Oregon, Oregon State filed Critical University of Oregon
Priority to AU2003211083A priority Critical patent/AU2003211083A1/en
Publication of WO2003069309A2 publication Critical patent/WO2003069309A2/fr
Publication of WO2003069309A3 publication Critical patent/WO2003069309A3/fr
Anticipated expiration legal-status Critical
Priority to US10/997,819 priority patent/US20050153381A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Des anomalies du complexe I sont l'une des causes les plus fréquentes de maladies et de troubles associés à des troubles de la chaîne respiratoire mitochondriale, notamment des maladies génétiquement associées, et des maladies neurodégénératives à début tardif. L'invention concerne des méthodes d'utilisation d'anticorps monoclonaux qui réagissent aux sous-unités du complexe I de 39, 30, 20, 18, 15, et 8-kDa de façon à aider à diagnostiquer les carences de complexe I. Ces procédés consistent à effectuer un criblage rapide permettant de détecter le début d'une variété de maladies ou la phase dans laquelle elle se trouve. L'invention concerne en outre des procédés de criblage d'agents, tels que des médicaments, pour déterminer leur effet sur l'activité du complexe I et des procédés de dépistage de patients dont l'activité du complexe I est altérée et de patients suspects d'avoir une maladie à début tardif associée à la modification post-translationnelle d'au moins une sous-unité du complexe I.
PCT/US2003/004567 2002-02-14 2003-02-14 Dosage immunocapteur et fonctionnel pour complexe i mitochondrial Ceased WO2003069309A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003211083A AU2003211083A1 (en) 2002-02-14 2003-02-14 Immunocapture and functional assay for mitochondrial complex i
US10/997,819 US20050153381A1 (en) 2002-02-14 2004-11-24 Immunocapture of mitochondrial protein complexes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35744102P 2002-02-14 2002-02-14
US60/357,441 2002-02-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US91725404A Continuation 2002-02-14 2004-08-11

Publications (2)

Publication Number Publication Date
WO2003069309A2 WO2003069309A2 (fr) 2003-08-21
WO2003069309A3 true WO2003069309A3 (fr) 2003-12-31

Family

ID=27734751

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/004567 Ceased WO2003069309A2 (fr) 2002-02-14 2003-02-14 Dosage immunocapteur et fonctionnel pour complexe i mitochondrial

Country Status (2)

Country Link
AU (1) AU2003211083A1 (fr)
WO (1) WO2003069309A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005976A1 (fr) * 1987-12-22 1989-06-29 Pharmacia Ab Procede de diagnostic de la cirrhose bilaire primaire et anticorps adaptes pour etre utilises dans ledit procede
US5888498A (en) * 1995-03-03 1999-03-30 Mitokor Cellular and animal models for diseases associated with mitochondrial defects

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005976A1 (fr) * 1987-12-22 1989-06-29 Pharmacia Ab Procede de diagnostic de la cirrhose bilaire primaire et anticorps adaptes pour etre utilises dans ledit procede
US5888498A (en) * 1995-03-03 1999-03-30 Mitokor Cellular and animal models for diseases associated with mitochondrial defects

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FANG ET AL.: "Isolation and characterization of complex I, rotenone-sensitive NADH:ubiquinone oxidoreductase, from the procyclic forms of trypanosoma brucei", EUR. J. BIOCHEM., vol. 268, 2001, pages 3075 - 3082, XP002967161 *
PETTUS ET AL.: "Immunocytochemical characterization of the mitochondrially encoded ND1 subunit of complex I (NADH;Ubiquinone oxidoreductase) in rat brain", JOURNAL OF NEUROCHEMISTRY, vol. 75, no. 1, 2000, pages 383 - 392, XP002967160 *
WILLIAMS ET AL.: "Immunological phenotyping of fibroblast cultures from patients with a mitochondrial respiratory chain deficit", LABORATORY INVESTIGATION, vol. 81, 2001, pages 1069 - 1077, XP002967159 *

Also Published As

Publication number Publication date
AU2003211083A8 (en) 2003-09-04
WO2003069309A2 (fr) 2003-08-21
AU2003211083A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
Milberger et al. Associations between ADHD and psychoactive substance use disorders: Findings from a longitudinal study of high-risk siblings of ADHD children
Toprak et al. Self-harm, suicidal ideation and suicide attempts among college students
DK3070174T3 (da) Opsporing af lægemidler på grundlag af in vitro-differentierede celler
WO2004059293A3 (fr) Marqueurs de diagnostic differentiel et procedes d'utilisation
WO2003070894A3 (fr) Test diagnostique non invasif mettant en oeuvre des marqueurs de modification de l'histone
WO2001020018A8 (fr) Procedes et compositions pour diagnostiquer et traiter des troubles arthritiques et reguler la masse osseuse
WO2007086986A3 (fr) Nouvelle application des biocapteurs pour le diagnostic et le traitement de maladies
BR0111473A (pt) Métodos para triar um indivìduo quanto a uma doença de armazenagem de glicogênio, para triar um indivìduo quanto à doença de pompe, para monitorar a condição clìnica de um indivìduo com doença de pompe, para estimar a eficácia de um regime terapêutico em um indivìduo com doença de pompe e para determinar a concentração de um oligossacarìdeo em uma amostra biológica
IL172871A (en) Isolated human antibody or antigen-binding section, training linker, single-chain antibody molecule, polypeptide containing them and their use
WO2008137838A3 (fr) Marqueurs pharmacodynamiques alpha-induit d'interféron
EP1931800A4 (fr) Systemes et methodes d'enrichissement d'analytes
EP2312312A3 (fr) Détection de protéines altérées à conformation et prions
EP1571160A4 (fr) Trousse d'analyse de cd14 humain de faible poids moleculaire et anticorps associe
WO2003004045A3 (fr) Procedes permettant d'identifier des agents therapeutiques pour traiter des maladies impliquant des polypeptides wnt et des recepteurs wnt
WO2006024466A3 (fr) Dispositif d'essai pour diagnostic in vitro d'essais multi-analytes et son utilisation
IL163900A (en) Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody
WO2007000320A3 (fr) Procede pour le diagnostic de maladies rhumatismales
DE10082504D2 (de) Indikatorpeptid zur Diagnose und/oder Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen, Antikörperzusammensetzung und immunoassay
WO2004045376A3 (fr) Methodes de criblage permettant d'identifier des traitements contre une maladie auto-immune
WO2003069309A3 (fr) Dosage immunocapteur et fonctionnel pour complexe i mitochondrial
WO2004083241A3 (fr) Proteines interagissant avec btc et utilisation de ces proteines
BR0317404A (pt) Variantes do fator xiia
WO2004039312A3 (fr) Optineurine et glaucome
WO2003036261A3 (fr) Mise au point d'un medicament par neuroimagerie rapide de cellules neuronales
RU2002132759A (ru) Способ прогнозирования развития рецидива при раке тела матки

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP